The Journal of Immunology, Vol 155, Issue 1 35-44, Copyright © 1995 by American Association of Immunologists

ARTICLES

A novel canine leukointegrin, alpha d beta 2, is expressed by specific macrophage subpopulations in tissue and a minor CD8+ lymphocyte subpopulation in peripheral blood

DM Danilenko, PV Rossitto, M Van der Vieren, H Le Trong, SP McDonough, VK Affolter and PF Moore
Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis 95616, USA.

The beta 2 or leukointegrin family is comprised of three structurally related leukocyte surface heterodimers: LFA-1 (CD11a/CD18), Mac-1/Mo-1 (CD11b/CD18), and p150,95 (CD11c/CD18). In this work, we describe a novel canine beta 2 (CD18)-associated leukointegrin, designated alpha d. Expression of alpha d in tissues was prominent in macrophages in splenic red pulp, lymph node medullary regions, and bone marrow. In peripheral blood, alpha d expression was limited to a minor subpopulation of CD8+ T cells, which included small lymphocytes and large granular lymphocytes. A minor subpopulation of either CD8+ or CD4- CD8- splenic red pulp lymphocytes also expressed alpha d. Immunoprecipitation of alpha d from canine splenocytes revealed a heterodimer of 155 kDa and 95 kDa. Prior clearance of splenocyte extracts with an anti-CD18 mAb resulted in complete removal of alpha d. In addition, prior clearance of canine splenocyte extracts with anti- CD11a, anti-CD11b, or anti-CD11c mAb failed to clear alpha d. These immunoclearance data indicated that canine alpha d was antigenically distinct from the three known CD11 molecules, and occurred as an alpha d beta 2 heterodimer. Amino acid sequencing of canine alpha d affinity isolated from spleen further suggested that canine alpha d beta 2 probably represented a fourth member of the canine leukointegrin family via its homology to a subsequently discovered, novel human leukointegrin, alpha d beta 2, which further supported the uniqueness of the canine protein. The discovery of canine alpha d, and the demonstration of its highly restricted cell and tissue distribution, support a re-evaluation of leukointegrin-dependent inflammatory and immunologic interactions that involve cells now known to express alpha d.

This article has been cited by other articles:

				Y. Miyazaki, M. Bunting, D. M. Stafforini, E. S. Harris, T. M. McIntyre, S. M. Prescott, V. S. Frutuoso, F. C. Amendoeira, D. de Oliveira Nascimento, A. Vieira-de-Abreu, et al. Integrin {alpha}D 2 Is Dynamically Expressed by Inflamed Macrophages and Alters the Natural History of Lethal Systemic Infections J. Immunol., January 1, 2008; 180(1): 590 - 600. [Abstract] [Full Text] [PDF]

				P. F. Moore, V. K. Affolter, and W. Vernau Canine Hemophagocytic Histiocytic Sarcoma: A Proliferative Disorder of CD11d+ Macrophages. Vet. Pathol., September 1, 2006; 43(5): 632 - 645. [Abstract] [Full Text] [PDF]

				P. Roccabianca, W. Vernau, M. Caniatti, and P. F. Moore Feline Large Granular Lymphocyte (LGL) Lymphoma with Secondary Leukemia: Primary Intestinal Origin with Predominance of a CD3/CD8{alpha}{alpha} Phenotype Vet. Pathol., January 1, 2006; 43(1): 15 - 28. [Abstract] [Full Text] [PDF]

				J. D. Noti, A. K. Johnson, and J. D. Dillon The Zinc Finger Transcription Factor Transforming Growth Factor {beta}-Inducible Early Gene-1 Confers Myeloid-specific Activation of the Leukocyte Integrin CD11d Promoter J. Biol. Chem., June 25, 2004; 279(26): 26948 - 26958. [Abstract] [Full Text] [PDF]

				M. M. Fry, W. Vernau, P. A. Pesavento, C. Bromel, and P. F. Moore Hepatosplenic Lymphoma in a Dog Vet. Pathol., September 1, 2003; 40(5): 556 - 562. [Abstract] [Full Text] [PDF]

				T. Willeke, J. Schymeinsky, P. Prange, S. Zahler, and B. Walzog A role for Syk-kinase in the control of the binding cycle of the {beta}2 integrins (CD11/CD18) in human polymorphonuclear neutrophils J. Leukoc. Biol., August 1, 2003; 74(2): 260 - 269. [Abstract] [Full Text] [PDF]

				S. P. McDonough and P. F. Moore Clinical, Hematologic, and Immunophenotypic Characterization of Canine Large Granular Lymphocytosis Vet. Pathol., November 1, 2000; 37(6): 637 - 646. [Abstract] [Full Text] [PDF]

				T. Willeke, S. Behrens, K. Scharffetter-Kochanek, P. Gaehtgens, and B. Walzog {beta}2 Integrin (CD11/CD18)-mediated signaling involves tyrosine phosphorylation of c-Cbl in human neutrophils J. Leukoc. Biol., August 1, 2000; 68(2): 284 - 292. [Abstract] [Full Text]

				B. WALZOG, P. WEINMANN, F. JEBLONSKI, K. SCHARFFETTER-KOCHANEK, K. BOMMERT, and P. GAEHTGENS A role for {beta}2 integrins (CD11/CD18) in the regulation of cytokine gene expression of polymorphonuclear neutrophils during the inflammatory response FASEB J, October 1, 1999; 13(13): 1855 - 1865. [Abstract] [Full Text]

				E. D. Bell, A. P. May, and D. L. Simmons The Leukocyte Function-Associated Antigen-1 (LFA-1)-Binding Site on ICAM-3 Comprises Residues on Both Faces of the First Immunoglobulin Domain J. Immunol., August 1, 1998; 161(3): 1363 - 1370. [Abstract] [Full Text] [PDF]

				K. Scharffetter-Kochanek, H. Lu, K. Norman, N. van Nood, F. Munoz, S. Grabbe, M. McArthur, I. Lorenzo, S. Kaplan, K. Ley, et al. Spontaneous Skin Ulceration and Defective T Cell Function in CD18 Null Mice J. Exp. Med., July 1, 1998; 188(1): 119 - 131. [Abstract] [Full Text] [PDF]

				T. P. Shanley, R. L. Warner, L. D. Crouch, G. N. Dietsch, D. L. Clark, M. M. O'Brien, W. M. Gallatin, and P. A. Ward Requirements for {alpha}d in IgG Immune Complex-Induced Rat Lung Injury J. Immunol., January 15, 1998; 160(2): 1014 - 1020. [Abstract] [Full Text] [PDF]

				S. W. Hunt III, E. S. Harris, S.-A. Kellermann, and Y. Shimizu T-Lymphocyte Interactions With Endothelium and Extracellular Matrix Critical Reviews in Oral Biology & Medicine, January 1, 1996; 7(1): 59 - 86. [Abstract] [Full Text] [PDF]

				E. S. Harris, T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman The Leukocyte Integrins J. Biol. Chem., July 28, 2000; 275(31): 23409 - 23412. [Full Text] [PDF]